Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

PPAR modulators and their use presented in recent patents

Oct. 13, 2003

Dosing completed in TOP study of Preos

Oct. 10, 2003

Approvable letter for insulin detemir

Oct. 10, 2003

Genzyme and Transkaryotic enter agreement for I2S for Hunter's syndrome

Oct. 10, 2003

Phase III trial initiated for Bio-E-Gel

Oct. 10, 2003

Several series of glycogen phosphorylase inhibitors described by AstraZeneca

Oct. 10, 2003

Novel PPAR agonists developed by GSK scientists

Oct. 10, 2003

Second- and third-generation oral contraceptives used in female hirsutism

Oct. 9, 2003

Bone anabolic effects of Apomine in mice

Oct. 8, 2003

CHF-4227: profile of a new SERM for osteoporosis

Oct. 8, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...